$WIX

Wix.com stock rating reiterated at Buy by StoneX on AI margins

StoneX reiterated a Buy rating and $110 price target for Wix.com (WIX) after meeting with the company, citing strong AI platform performance and potential margin upside. WIX trades at $79.67, with analysts noting undervaluation and a 12% free cash flow yield. Recent Q2 results beat estimates, with revenue of $563.1M and EPS of $1.59. Analysts have mixed price target adjustments but acknowledge the earnings beat.

Original reporting
Published Sep 21, 2026, 2:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WIX
Neutral
medium confidence
Mentioned
$WIX · $SNEX
Relevance
4/10
AlphAI data visualization · based on uk.investing.com
Decision brief

The 30-second read

$WIXNeutralLow
01

Why it matters

Rating reaffirmation may provide slight upside, but earnings already reflected in price; limited new actionable insight.

02

Market read

Provides a brief analyst perspective on Wix.com post‑earnings, with limited new trading impetus.

03

What to watch

Potential competitive pressure from larger website platforms and the $50 M bookings headwind in the Partners channel.

Relevance 4/10Novelty 2/10Timing: post‑earnings recap

Background

Analyst coverage update following Wix.com's Q2 earnings beat and AI platform performance.

Company-level read

Ticker impact

$WIXNeutralMedium confidence
Context

StoneX reiterated a Buy rating and $110 price target for Wix.com after its Q2 earnings beat and AI platform performance.

Expected impact

Potential modest price appreciation if investors follow the rating, but limited upside due to reinvestment of margins.

Evidence & confidence

Rating change is a reiteration, not a new catalyst; earnings beat already priced in.

Market effects

Highlights AI platform adoption in website‑builder sector, but no immediate sector‑wide shift.

US‑focused, limited broader regional effect.

Minimal global impact beyond Wix investors.

Counterpoint

Rating reiteration may be overly optimistic given margin reinvestment and modest AI revenue contribution.

Key entities

  • Wix.com

    Website‑building platform with AI‑enhanced services.

  • StoneX

    Research firm reiterating Buy rating on Wix.com.

Related articles

$CRWDMed

CRWD Maintained by StoneX -- Price Target Raised to $325

StoneX analyst Yi Fu Lee maintained a 'Buy' rating on CrowdStrike (CRWD) and raised the price target from $250 to $325. The stock is currently priced at $272.67, which is 97.7% overvalued according to GF Value™. CrowdStrike's GF Score™ is 71/100, indicating strong growth and momentum but poor valuation. Insider activity shows significant selling, with $451 million in sales over the past three months.

$TXRHMed

Texas Roadhouse upgraded to Buy from Hold at StoneX

StoneX upgraded Texas Roadhouse to Buy from Hold, setting a $200 price target. The analyst cites the company's leadership in casual dining and compelling risk/reward after a share pullback. Texas Roadhouse is seen as a high-quality operator that can widen its competitive advantage during economic stress.

$ROCMed

Rank One Computing stock price target maintained at $9 by StoneX

StoneX reiterated a Buy rating and $9 price target for Rank One Computing (NASDAQ:ROC), citing recent contract wins and improved pipeline velocity. The stock has fallen 44.6% over six months, trading at $4.05. The company reported a 2% revenue increase in Q2 2026, with a gross profit margin of nearly 80%. Management extended lock-up agreements until February 2027.

$WIXMed

Wix (WIX) Stock Trades Down, Here Is Why

Wix (WIX) shares fell 5.1% after Gen Digital approached GoDaddy, pressuring web services sector. Investors questioned Gen Digital's ability to complete the deal due to high net debt. Wix's stock later recovered to $74.62, down 3.8% from the previous close. The stock has seen significant volatility, down 26.1% year-to-date and 58.7% from its 52-week high.

$SNEXMed

StoneX (SNEX) Turns Mortgage Bond Complexity Into New Revenue

StoneX Group (SNEX) launched a synthetic credit structure with DeltaTerra for mortgage bonds, enabling institutional investors to gain exposure via credit default swaps. The company reported strong fiscal Q3 results, with revenue up 47% and net income more than doubling. Growth was driven by commercial and institutional segments, while retail segment revenue declined. Interest expenses and variable costs increased, and a new structured product aims to capitalize on a market event. Hedge funds ha